FRAXA awarded a $100,000 grant to Dr. Davidson and Dr. Yrigollen at Children’s Hospital of Philadelphia to explore gene editing tools aimed at treating Fragile X syndrome by correcting FMR1 mutations in a unique mouse model.
Read moreYrigollen, Carolyn
Dr. Carolyn Yrigollen is a Research Associated Scientist II at Children’s Hospital of Philadelphia (CHOP) and a FRAXA Postdoctoral Fellow in Dr. Davidson’s lab.